Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia

• Status: Withdrawn
• Trial end date: 2007-10-01

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more cancer cells.

PURPOSE: Phase I/II trial to study the effectiveness of combination chemotherapy followed by peripheral stem cell transplantation in treating patients with chronic myelogenous leukemia.

• Phase: Phase 1/Phase 2

Details

• Lead Sponsor: Columbia University
• Treatments: Busulfan; Cyclophosphamide; Cyclosporine; Cyclosporins; Cytarabine; Idarubicin; Interferon-gamma; Interferons